Track the BioArctic AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, BioArctic AB (publ) has recorded 0 reports. Market capitalisation: €28.4bn. Every trade is free.
Analysts rate BioArctic AB (publ) Buy (bullish), based on 4 analysts. Average price target: SEK 316.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
BioArctic AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).